Research highlights potential of blood epigenetics for dementia risk assessment Post author: Post published:August 28, 2024 Post category:uncategorized New research suggests that epigenetic markers in the blood could be useful for understanding dementia risk. You Might Also Like New anti-lipid antibodies could improve diagnosis of Lyme disease June 30, 2026 Researchers identify early molecular warning signs of inflammatory bowel disease August 29, 2026 The horrors of TMJ: Chronic pain, metal jaws, and futile treatments April 4, 2024